SCHEMBL7119275

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL7112009	0.87	KDR (0.76)	JAK3EGFRKDRRETGAK
	SCHEMBL30925305	0.85	JAK3 (1.00)	JAK3MKNK1EGFRKDRRET
	SCHEMBL6668470	0.85	JAK3 (0.73)	JAK3MKNK1EGFRKDRRET
	SCHEMBL323445	0.85	JAK3 (1.00)	JAK3MKNK1EGFRKDRRET
	SCHEMBL5864555	0.85	KDR (0.73)	JAK3MKNK1EGFRKDRRET
	SCHEMBL5473780	0.82	EGFR (0.78)	JAK3EGFRKDRRETGAK
	Whi-P131 SCHEMBL29369589	0.82	EGFR (1.00)	JAK3EGFRKDRRETGAK
	Whi-P131 SCHEMBL29295	0.82	EGFR (1.00)	JAK3EGFRKDRRETGAK
	SCHEMBL6181483	0.82	EGFR (1.00)	JAK3MKNK1EGFRKDRRET
	SCHEMBL5649600	0.82	KDR (1.00)	JAK3MKNK1EGFRKDRRET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.